# Clive Ballard

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/clive-ballard/

## Facts

| Field | Value |
| --- | --- |
| Citations | 105,409 |
| Field | Dementia and Cognitive Impairment Research |
| h-index | 140 |
| i10-index | 606 |
| Last Known Institution | University of Exeter |
| OpenAlex ID | https://openalex.org/A5032708452 |
| ORCID iD | https://orcid.org/0000-0003-0022-5632 |
| Works | 1,210 |

## Researcher papers

Showing 12 of 15.

- [Dementia prevention, intervention, and care: 2020 report of the Lancet Commission](https://scholariq.org/papers/dementia-prevention-intervention-and-care-2020-report-of-the-lancet-commission/)
- [Dementia prevention, intervention, and care](https://scholariq.org/papers/dementia-prevention-intervention-and-care/)
- [Multidisciplinary research priorities for the COVID-19 pandemic: a call for action for mental health science](https://scholariq.org/papers/multidisciplinary-research-priorities-for-the-covid-19-pandemic-a-call-for/)
- [Diagnosis and management of dementia with Lewy bodies](https://scholariq.org/papers/diagnosis-and-management-of-dementia-with-lewy-bodies/)
- [Consensus guidelines for the clinical and pathologic diagnosis of dementia with Lewy bodies (DLB)](https://scholariq.org/papers/consensus-guidelines-for-the-clinical-and-pathologic-diagnosis-of-dementia-with/)
- [Defeating Alzheimer's disease and other dementias: a priority for European science and society](https://scholariq.org/papers/defeating-alzheimer-s-disease-and-other-dementias-a-priority-for-european/)
- [Donepezil and Memantine for Moderate-to-Severe Alzheimer's Disease](https://scholariq.org/papers/donepezil-and-memantine-for-moderate-to-severe-alzheimer-s-disease/)
- [Physical, cognitive, and mental health impacts of COVID-19 after hospitalisation (PHOSP-COVID): a UK multicentre, prospective cohort study](https://scholariq.org/papers/physical-cognitive-and-mental-health-impacts-of-covid-19-after-hospitalisation/)
- [The dementia antipsychotic withdrawal trial (DART-AD): long-term follow-up of a randomised placebo-controlled trial](https://scholariq.org/papers/the-dementia-antipsychotic-withdrawal-trial-dart-ad-long-term-follow-up-of-a/)
- [Core outcome measures for interventions to prevent or slow the progress of dementia for people living with mild to moderate dementia: Systematic review and consensus recommendations](https://scholariq.org/papers/core-outcome-measures-for-interventions-to-prevent-or-slow-the-progress-of/)
- [Management of agitation and aggression associated with Alzheimer disease](https://scholariq.org/papers/management-of-agitation-and-aggression-associated-with-alzheimer-disease/)
- [Neuropsychiatric symptoms in Alzheimer's disease: Past progress and anticipation of the future](https://scholariq.org/papers/neuropsychiatric-symptoms-in-alzheimer-s-disease-past-progress-and-anticipation/)

## Researcher topics

- [Dementia and Cognitive Impairment Research](https://scholariq.org/topics/dementia-and-cognitive-impairment-research/)
- [Alzheimer's disease research and treatments](https://scholariq.org/topics/alzheimer-s-disease-research-and-treatments/)
- [Parkinson's Disease Mechanisms and Treatments](https://scholariq.org/topics/parkinson-s-disease-mechanisms-and-treatments/)
- [Schizophrenia research and treatment](https://scholariq.org/topics/schizophrenia-research-and-treatment/)
- [Cholinesterase and Neurodegenerative Diseases](https://scholariq.org/topics/cholinesterase-and-neurodegenerative-diseases/)

## Researcher university

- [University of Exeter](https://scholariq.org/institutions/university-of-exeter/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.